Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)
BB Biotech AG / Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- Details of the person subject to the disclosure requirement -------------------------------------------------------------------------------- Name: ...
Comunicato Precedente
Comunicato Successivo
New York,
(informazione.it - comunicati stampa - economia)
Copyright GlobeNewswire
Regulatory News
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: %s via Globenewswire
[HUG#1984183]
Details of the person subject to the disclosure requirement | |
Name: | Strein, Klaus |
Professional role: | Person with executive functions: Member of administrative or supervisory body |
Designation of the financial instrument | |
ISIN: | CH0038389992 |
Designation: | Registered share BB Biotech AG |
Details of the transaction | |
Type of transaction: | Buy |
Date: | 04.02.2016 |
Place (stock exchange): | Swiss Stock Exchange |
Price: | 229.463 |
Currency: | CHF |
Quantity: | 2600 |
Business volume: | 596603.80 |
Details of the company with the publishing obligation: | |
Issuer: | |
BB Biotech AG | |
Schwertstrasse 6 | |
CH-8200 Schaffhausen | |
Switzerland |
ISIN: | CH0038389992 |
WKN: | 888509 |
Copyright GlobeNewswire
Regulatory News
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: %s via Globenewswire
[HUG#1984183]
Per maggiori informazioni
Sito Web
http://www.bbbiotech.com
Ufficio Stampa